Patent intelligence · CN
CN 112996764
CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF
CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF
Patent details — CN 112996764
- Jurisdiction
- CN
- Status
- granted
- Grant date
- Jun 18, 2021
- Expiration
- Jun 13, 2041
- Applicant
- BRACCO IMAGING SPA
- CPC classes
- A61K 49/ 00 A I, A61K 49/ 14 A I, A61K 51/ 08 A I, A61K/490002
Quick answer
CN 112996764 (CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF) is held by BRACCO IMAGING SPA. Status: granted. Granted Jun 18, 2021. Expires Jun 13, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BRACCO IMAGING SPA
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 49/ 00 A I, A61K 49/ 14 A I, A61K 51/ 08 A I, A61K/490002, A61K/4914, A61K/5108
More from BRACCO IMAGING SPA
Related pharmaceutical patents in our USPTO index.
-
CN 119365549
Fluorescent probe targeting CA-IX
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
CN 119325492
Fluorescent probe targeting CA-IX
granted -
CN 118401500
Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes
granted -
US 2024131199
PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20240034693
이량체 조영제의 제조
granted -
US 2023312523
NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF
granted -
KR 20230116805
가도테리돌 제조를 위한 제조 방법
granted
Frequently asked questions
What is US patent 112996764?
CN 112996764 (CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF) is held by BRACCO IMAGING SPA. Status: granted. Granted Jun 18, 2021. Expires Jun 13, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CN 112996764?
BRACCO IMAGING SPA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CN 112996764 expire?
Our index shows an expiration date of Jun 13, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.